close

Enter

Log in using OpenID

Injectable Nanomedicines Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2029

embed
Injectable nanomedicines market to value over USD 400 Million by 2029 end and register a CAGR of over 8% from 2019 to 2029.
Injectable Nanomedicines Market Global Trends, Market Share, Industry Size,
Growth, Opportunities, and Market Forecast 2019 to 2029
Injectable nanomedicines market to value over USD 400 Million by 2029 end and
register a CAGR of over 8% from 2019 to 2029.
Nanomedicines are minute sized drugs used specifically to target some section,
having minimal toxic effects, and more effective. These drugs are administered orally
or intravenously, while others are pure and injectable, given in small volumes.
These drugs provide better disease management with specific targeted drug delivery
which is estimated to lead to a higher demand for injectable nanomedicines. The
efficient and compact design of nanoparticles is becoming increasingly popular and
expanding the market. For instance, liposomal technologies are employed by firms
for extended-release drug delivery thereby decreasing the number of dosages. These
include DepoFoam TM Technology, Non-PEGylated Technology (NPL) and others.
These technologies improve patient drug adherence through decreased dosing and
minimal side effects. To further elucidate, quick ready adoption of advanced
technologies for manufacturing unique medicines is expected to support revenue
growth of injectable nanomedicines market over the forecast period.
Government funds are increasing which is attracting other firms, expanding the
market. In this regard, the U.S. Federal Authorities have provided funding worth US$
1.4 Bn under the National Nanotechnology Initiative, confirming the growing
importance and interest on nanomedicines. The growing use and application of
nanomedicines is the cause behind this, helping the market to expand globally.
Scientific and technological expertise coupled with strong academic research ensures
better drug development. This factor is expected to boost the injectable
nanomedicines industry favourably with faster market outreach.
Request a Sample Report @ https://www.futurewiseresearch.com/requestsample.aspx?id=257&page=requestsample
Global Injectable Nanomedicines Market Segmentation
By Drug Type
● Liposomes
● Micelles
● Nanocrystals
● Polymeric Nanoparticles
● Metallic Nanoparticles
● Mesoporous Silica Nanoparticles
● Others
By Application
● Cancers
● Central Nervous System Diseases
● Cardiovascular diseases
● Infection Control
● Inflammatory Diseases
● Others
By End User
● Hospitals
● Ambulatory Surgical Centers
● Clinics
● Specialized Drugs R&D Institutes
● Managed Care Organizations
By Region:
● Europe
● North America
● APAC
● Latin America
● Rest of World
North America is likely to lead the global injectable nanomedicines market in the
near future. This is attributed to the increasing focus on diseases surveillance and the
availability of progressive healthcare facilities. The market of injectable
nanomedicine in Europe is expected to rise considerably due to the high availability
of GMP certified sterile manufacturing facilities.
The developing regions in the Asia Pacific are also anticipated to expand the global
injectable nanomedicines market. Growing prevalence of various infectious diseases
and increasing investment in the healthcare sector in developing economies to
further fuel growth in this market.
Purchase a Copy of this Premium Research Report & Ask for Discount:
https://www.futurewiseresearch.com/requestsample.aspx?id=257&page=askfordiscount
Competitive Landscape:
● Tier 1 players- established companies in the market with a major market share
● Tier 2 players
● Emerging players which are growing rapidly
● New Entrants
The significant firms operating in the injectable nanomedicines market are Merck
KGaA, Amgen Inc., Pfizer Inc., Lupin, Janssen Biotech Inc., Hoffmann-La Roche Ltd.,
Teva Pharmaceutical Industries Ltd., Pacira Pharmaceuticals Inc., Celgene
Corporation and Bausch & Lomb Incorporated. Emerging players operating in the
injectable nanomedicines market are focusing on new marketing strategies in order
to expand their product footprint in the global injectable nanomedicines market.
They are investing in R&D for development of innovative nanomedicines, currently,
there are several injectable nanomedicines under clinical trials and are expected to
launch in recent years which is likely to upsurge the competition in injectable
nanomedicine market.
FutureWise Key Takeaways
● Growth prospects
● SWOT analysis
● Key trends
● Key data points affecting market growth
Objectives of the Study:
● To provide an exhaustive analysis on injectable nanomedicines by drug type, by
application and region
● To cater comprehensive information on factors impacting market growth
(drivers, restraints, opportunities, and industry-specific restraints)
● To evaluate and forecast micro-markets and overall market
● To predict the market size, in key regions (along with countries)—North America,
Europe, Asia Pacific, Latin America, and the Middle East and Africa
● To record evaluate and competitive landscape mapping- product launches,
technological advancements, mergers and expansions
● Profiling of companies to evaluate their market shares, strategies, financials and
core competencies
Table of Contents
1. Market Introduction
1.1. Market Taxonomy
1.2. Market Definition
2. Executive Summary
2.1. Market Overview
2.2. Market Analysis
3. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Trends
4. Key Inclusions
4.1. Nanomedicines Development Over Time
4.2. Regulatory Scenario
4.3. Disease Epidemiology
4.4. Approvals of Commercial Injectable Nanomedicines
5. Injectable nanomedicines Market Value (US$ Mn) Analysis By Drug Type







Liposomes
Micelles
Nanocrystals
Polymeric Nanoparticles
Metallic Nanoparticles
Mesoporous Silica Nanoparticles
Others
6. Injectable nanomedicines Market Value (US$ Mn) Analysis By Application






Cancers
Central Nervous System Diseases
Cardiovascular diseases
Infection Control
Inflammatory Diseases
Others
7. Injectable nanomedicines Market Size (US$ Mn) Analysis By End User





Hospitals
Ambulatory Surgical Centers
Clinics
Specialized Drugs R&D Institutes
Managed Care Organizations
8. North America Injectable Nanomedicines Market Analysis 2014–2018 and
Forecast 2019–2029
8.1. Introduction
8.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2014–2018
8.2.1. U.S.
8.2.2. Canada
9. Latin America Injectable Nanomedicines Market Analysis 2014–2018 and
Forecast 2019–2029
9.1. Introduction
9.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2014–2018
9.2.1. Brazil
9.2.2. Mexico
9.2.3. Rest of Latin America
10. Europe Injectable Nanomedicines Market Analysis 2014–2018 and Forecast
2019–2029
10.1. Introduction
10.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2014–2018
10.2.1. Germany
10.2.2. U.K.
10.2.3. France
10.2.4. Italy
10.2.5. Spain
10.2.6. Russia
10.2.7. Rest of Europe
10.3. By Drug Type
10.4. By Application
10.5. By End User
11. Asia Pacific Injectable Nanomedicines Market Analysis 2014–2018 and Forecast
2019–2029
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2014–2018
11.2.1. Japan
11.2.2. China
11.2.3. India
11.2.4. Australia and New Zealand
11.2.5. Rest of Asia Pacific
12. Middle East & Africa Injectable Nanomedicines Market Analysis 2014–2018 and
Forecast 2019–2029
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2014–2018
12.2.1. GCC Countries
12.2.2. South Africa
12.2.3. Rest of MEA
13. Competition Analysis









Merck & Co., Inc.
Lupin
Pacira Pharmaceuticals Inc.
Celgene Pharmaceutical Co. Ltd.
Amgen, Inc.
Janssen Biotech Inc. (Sub. Johnson & Johnson Services, Inc.)
Pfizer Inc.
Hoffmann-La Roche Ltd.
Teva Pharmaceutical Industries Ltd.

Bausch & Lomb Incorporated.
Inquire further details about this report at: [email protected]
About FutureWise Research:
We specialise in high-growth niche markets, assuring flexibility, agility and
customised solutions for our clients. Through in-depth market insights and
consultancy, we present our clients with the tools they need to be at the forefront of
their industry – a position secured for far more than the near future.
Contact Us:
Company Name: FutureWise Research
Contact Person: Vinay Thaploo
Email: [email protected]
Phone: +44 141 628 9353 / +1 970 279 4295
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com
1/--pages
Report inappropriate content